Association of a long‐chain fatty acid‐CoA ligase 4 gene polymorphism with depression and with enhanced niacin‐induced dermal erythema
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Hypotheses about relationships between changes in membrane lipids and mental illness have focused primarily on three long‐chain polyunsaturated fatty acids: arachidonic acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). Membrane deficiencies of these fatty acids have been reported in schizophrenia (AA, EPA, and DHA) and in depression (EPA and DHA). Long‐chain fatty acid‐CoA ligase type 4 (FACL4; MIM 300157) is a key enzyme involved in the metabolism of AA, EPA, and DHA. FACL4 selectively esterifies these fatty acids with co‐enzyme A, forming acyl‐co‐A, which can then be incorporated into membrane phospholipid. We used niacin‐induced dermal erythema as one index of AA metabolism to identify a common C to T single nucleotide polymorphism (SNP) in the first intron of the FACL4 gene (Xq22.3), which is associated with enhanced dermal erythema in both schizophrenia and control subjects. Male subjects with the T0 genotype showed greater dermal erythema following topical application of methylnicotinate, suggesting that this polymorphism may be in linkage disequilibrium with a functional polymorphism of the FACL4 gene that modulates re‐sequestration of agonist‐released free AA. We also examined the allele frequency of this polymorphism in 555 European–Americans (EA), including 229 control subjects, 198 subjects with major depression, 58 with schizophrenia or schizoaffective disorder, and 70 with alcohol dependence without co‐morbid psychiatric illness. We observed a significant excess of the T allele in subjects with major depression, as compared with controls (49% vs. 38%; P = 0.003) and a non‐significant excess of the T allele in schizophrenia (44%; P = 0.29). The allele frequency for subjects with alcohol dependence did not differ from controls. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Omega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-blind, Placebo-Controlled Trial
Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., Cress, K. K., & Marangell, L. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.407 · Cited by 814
Nemets, B., Stahl, Z., & Belmaker, R. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.477 · Cited by 627
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1195 · Cited by 332 · cited 2×
“…in 1 of 3 clinical trials for treatment of these co-morbid disorders were obtained using the psychiatric research interview for substance andmental disorders (PRISM), amodified version of the SCID with improved inter-rater reliability in subjects with substance dependence [Hasin et al., 1996].”
MethodPeet, M., Brind, J., Ramchand, C. N., Shah, S., & Vankar, G. K. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00083-9 · Cited by 329
Depletion of docosahexaenoic acid in red blood cell membranes of depressive patients
Edwards, R., Peet, M., Shay, J., & Horrobin, D. (1998) · Biochemical Society Transactions · doi:10.1042/bst026s142 · Cited by 44 · cited 1×
“Studies of plasma and red blood cell membrane phospholipid content of fatty acids indepressed subjectshave shownreduced content of EPA and DHA [Adams et al., 1996; Edwards et al., 1998; Peet et al., 1998;Maes et al., 1999].”
Background
Cited by
Meta-analyses of genetic studies on major depressive disorder
López-León, S., Janssens, A. C. J. W., González-Zuloeta Ladd, A. M., Del-Favero, J., Claes, S. J., Oostra, B. A., & van Duijn, C. M. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002088 · Cited by 493
Poor replication of candidate genes for major depressive disorder using genome-wide association data
Bosker, F. J., Hartman, C. A., Nolte, I. M., Prins, B. P., Terpstra, P., Posthuma, D., van Veen, T., Willemsen, G., DeRijk, R. H., de Geus, E. J., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.38 · Cited by 309
Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis
Bloch, M. H., & Hannestad, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.100 · Cited by 293
Long-Chain Acyl-Coa Synthetases And Fatty Acid Channeling
Mashek, D. G., Li, L. O., & Coleman, R. A. (2007) · Future Lipidology · doi:10.2217/17460875.2.4.465 · Cited by 279
Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
Ross, B. M., Seguin, J., & Sieswerda, L. E. (2007) · Lipids in Health and Disease · doi:10.1186/1476-511x-6-21 · Cited by 275
Marszalek, J. R., & Lodish, H. F. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120624 · Cited by 270
Donald, K. A., Eastman, E., Howells, F. M., Adnams, C., Riley, E. P., Woods, R. P., Narr, K. L., & Stein, D. J. (2015) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.12 · Cited by 185
Alisky, J. M. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500484638 · Cited by 38
“In another precedent for the concept that not everyone responds to niacin the same way, patients who showed heightened dermal erythema in response to niacin had a higher incidence of depression and also had a particular polymorphism in long-chain fatty acid-CoA ligase 4 (Covault et al. 2004).”
Background
Metadata
- Authors
- Covault, J., Pettinati, H., Moak, D., Mueller, T., & Kranzler, H. R.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2004-01-13
- Volume
- 127B
- Issue
- 1
- Pages
- 42-47
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W1980329209
- Cited by
- 67
- References
- 6
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.